Projects per year
Fingerprint
Dive into the research topics where Joseph A Vetro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Targeted Nanogels for siRNA Delivery to Tumor Vasculature
Project: Research project
-
-
Host-Directed Immunotherapy: A One Health Approach
Sanderson, S., Vetro, J. A. & Sanderson, S.
Project: Research project
-
Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer
Project: Research project
-
EP67-Based Targeted Mucosal Vaccines to Prevent Primary Infection with CMV
Project: Research project
-
Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC
Ye, Z., Abdelmoaty, M. M., Curran, S. M., Dyavar, S. R., Kumar, D., Alnouti, Y., Coulter, D. W., Podany, A. T., Singh, R. K. & Vetro, J. A., Feb 2022, In: Non-coding RNA. 8, 1, 8.Research output: Contribution to journal › Article › peer-review
Open Access -
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization
Parriott, J. E., Stewart, J. P., Smith, D. D., Curran, S. M., Bauer, C. D., Wyatt, T. A., Phillips, J. A., Lyden, E., Thiele, G. M. & Vetro, J. A., Sep 2022, In: Pharmaceutics. 14, 9, 1843.Research output: Contribution to journal › Article › peer-review
Open Access -
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer
Ye, Z., Abdelmoaty, M. M., Ambardekar, V. V., Curran, S. M., Dyavar, S. R., Arnold, L. L., Cohen, S. M., Kumar, D., Alnouti, Y., Coulter, D. W., Singh, R. K. & Vetro, J. A., Apr 2021, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 33, 102363.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
Alshammari, A. M., Smith, D. D., Parriott, J., Stewart, J. P., Curran, S. M., McCulloh, R. J., Barry, P. A., Iyer, S. S., Palermo, N., Phillips, J. A., Dong, Y., Ronning, D. R., Vennerstrom, J. L., Sanderson, S. D. & Vetro, J. A., May 8 2020, In: ACS infectious diseases. 6, 5, p. 1169-1181 13 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection
Tallapaka, S. B., Karuturi, B. V. K., Yeapuri, P., Curran, S. M., Sonawane, Y. A., Phillips, J. A., David Smith, D., Sanderson, S. & Vetro, J. A., Jun 30 2019, In: International journal of pharmaceutics. 565, p. 242-257 16 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations